Loading clinical trials...

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Randomized, Double-blind, Active-controlled, Multicenter, Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

NCT03408236•Hugel

View on ClinicalTrials.gov

Summary

To determine the efficacy and safety of Botulax® in treatment of crow's feet line

Detailed Description

1. Allocation: Randomized 2. Masking: Double Blind

Eligibility

Age

19 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Male or female of at least 19 to 65 years old
•Bilaterally symmetrical moderator-to-severe CFL at maximum smile on the FWS as rated by the investigator

Exclusion Criteria

•Subject with hypersensitivity to the investigational products or their components
•Female subject who are pregnant or lactating
•Subject who are unable to communicate or follow the instructions

Locations (1)

Hugel

Seoul, South Korea

Key Dates

Start Date

January 17, 2018

Primary Completion Date

December 13, 2018

Completion Date

June 7, 2019

Last Updated

April 15, 2022

Enrollment

240

ACTUAL participants

Conditions

Crow's Feet Lines

Interventions

Botulinum toxin type A

DRUG

Botulinum toxin type A

DRUG

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

NCT06402058

Crow's Feet Lines

View study

COMPLETEDPHASE3

BOTOX® in the Treatment of Crow's Feet Lines in Japan

NCT01797081

Lateral Canthus RhytidesCrow's Feet Lines

View study

COMPLETEDPHASE4

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 15, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Inclusion Criteria

Exclusion Criteria

A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

BOTOX® in the Treatment of Upper Facial Lines in Japan

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines